Companies / Canada
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Steady Growth Expected In Canada's Generics Market
May 2006 | Special ReportSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
These positive prospects aside, the expansion of Canada's generics market is likely to meet resistance. In 2006, US pharmaceutical companies again lobbied their government to make Canada's patenting conditions a priority in trade relations. If the country conceded demands to tighten rules on key issues such as early working, BMI believes the expansion of the country's off-patent sector could slow significantly in the coming